In a study involving an animal model of metabolic syndrome which is also associated with an increased risk of oxidative stress and inflammation, therapy with coenzyme Q10 was found to reduce cardiovascular risk associated with the metabolic syndrome. Therapy with coenzyme Q10 significantly:
- Decreased oxidative and inflammatory stress markers.
- Prevented the elevation in serum insulin levels.
- Reduced blood pressure.
- Improved blood vessel health.
The researchers concluded, "These findings suggest that the antioxidant properties of CoQ10 can be effective for ameliorating cardiovascular risk in metabolic syndrome."
As cholesterol lowering medications also cause coenzyme Q10 deficiency, I recommend that anybody taking these medications also supplement with coenzyme Q10 at a dose of 200 mg a day.
In addition, I recommend that males with metabolic syndrome have their testosterone levels optimized.
"Beneficial effect of coenzyme Q10 on increased oxidative and nitrative stress and inflammation and individual metabolic components developing in a rat model of metabolic syndrome," Kunitomo M, Yamaguchi Y, et al, J Pharmacol Sci, 2008; 107(2): 128-37.
Jacob Teitelbaum, M.D. is one of the world's leading integrative medical authorities on fibromyalgia and chronic fatigue. He is the lead author of four research studies on their treatments, and has published numerous health & wellness books, including the bestseller on fibromyalgia and chronic fatigue syndrome From Fatigued to Fantastic! and his newer The Fatigue and Fibromyalgia Solution. Dr. Teitelbaum is one of the most frequently quoted fibromyalgia experts in the world and appears often as a guest on news and talk shows nationwide including Good Morning America, The Dr. Oz Show, Oprah & Friends, CNN, and Fox News Health.